BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9864048)

  • 1. Comparison of antiviral compounds against human herpesvirus 6 and 7.
    Yoshida M; Yamada M; Tsukazaki T; Chatterjee S; Lakeman FD; Nii S; Whitley RJ
    Antiviral Res; 1998 Dec; 40(1-2):73-84. PubMed ID: 9864048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method for detection of HHV-6 antigens and its use for evaluating antiviral drugs.
    Yoshida M; Yamada M; Chatterjee S; Lakeman F; Nii S; Whitley RJ
    J Virol Methods; 1996 Apr; 58(1-2):137-43. PubMed ID: 8783159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric evaluation of antiviral agents against human herpesvirus 6.
    Amjad M; Gillespie MA; Carlson RM; Karim MR
    Microbiol Immunol; 2001; 45(3):233-40. PubMed ID: 11345533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6.
    Reymen D; Naesens L; Balzarini J; Holý A; Dvoráková H; De Clercq E
    Antiviral Res; 1995 Dec; 28(4):343-57. PubMed ID: 8669893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective activity of various antiviral compounds against HHV-7 infection.
    Zhang Y; Schols D; De Clercq E
    Antiviral Res; 1999 Aug; 43(1):23-35. PubMed ID: 10480261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis.
    Manichanh C; Grenot P; Gautheret-Dejean A; Debré P; Huraux JM; Agut H
    Cytometry; 2000 Jun; 40(2):135-40. PubMed ID: 10805933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines.
    Andrei G; Snoeck R; Piette J; Delvenne P; De Clercq E
    Oncol Res; 1998; 10(10):523-31. PubMed ID: 10338155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses.
    Williams SL; Hartline CB; Kushner NL; Harden EA; Bidanset DJ; Drach JC; Townsend LB; Underwood MR; Biron KK; Kern ER
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2186-92. PubMed ID: 12821466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzimidazole analogs inhibit human herpesvirus 6.
    Prichard MN; Frederick SL; Daily S; Borysko KZ; Townsend LB; Drach JC; Kern ER
    Antimicrob Agents Chemother; 2011 May; 55(5):2442-5. PubMed ID: 21300829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent advances in antiviral drugs--antiviral agents to HCMV, HHV-6, and HHV-7].
    Takahashi K
    Nihon Rinsho; 1998 Jan; 56(1):140-4. PubMed ID: 9465679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of (r)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (H2G) and AZT-lipid-PFA on human herpesvirus-6B infected cells.
    Yao K; Hoest C; Rashti F; Schott TC; Jacobson S
    J Clin Virol; 2009 Sep; 46(1):10-4. PubMed ID: 19524486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblasts.
    Naesens L; Bonnafous P; Agut H; De Clercq E
    J Clin Virol; 2006 Dec; 37 Suppl 1():S69-75. PubMed ID: 17276373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
    Andrei G; De Clercq E; Snoeck R
    Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral drug susceptibility of human herpesvirus 8.
    Neyts J; De Clercq E
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2754-6. PubMed ID: 9420052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry.
    Long MC; Bidanset DJ; Williams SL; Kushner NL; Kern ER
    Antiviral Res; 2003 Apr; 58(2):149-57. PubMed ID: 12742575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.
    Smee DF; Barnett BB; Sidwell RW; Reist EJ; Holy A
    Antiviral Res; 1995 Jan; 26(1):1-9. PubMed ID: 7741517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyurea potentiates the antiherpesvirus activities of purine and pyrimidine nucleoside and nucleoside phosphonate analogs.
    Neyts J; De Clercq E
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2885-92. PubMed ID: 10582877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of methylenecyclopropane analogs of nucleosides against herpesvirus replication in vitro.
    Kushner NL; Williams SL; Hartline CB; Harden EA; Bidanset DJ; Chen X; Zemlicka J; Kern ER
    Nucleosides Nucleotides Nucleic Acids; 2003 Dec; 22(12):2105-19. PubMed ID: 14714760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Herpesviruses 6A, 6B, and 7.
    Agut H; Bonnafous P; Gautheret-Dejean A
    Microbiol Spectr; 2016 Jun; 4(3):. PubMed ID: 27337451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus.
    Andrei G; Snoeck R; Reymen D; Liesnard C; Goubau P; Desmyter J; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1995 Apr; 14(4):318-29. PubMed ID: 7649195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.